Epichem provides services in medicinal chemistry to the pharmaceutical industry. Photo: Attila Csaszar

Epichem scales back revenue projections

PharmAust subsidiary Epichem has significantly revised its forecast revenue following the announcement one of its major customers would end its contract with the company next month.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

PharmAust (PAA)

Share Price

Closing price for the last 90 trading days
Powered by Morningstar ®

Top 10 Shareholders

Substantial shareholders as published in the annual report.
Powered by Morningstar ®

Company Documents